- Home
- SENEA vs MGTX Comparison
SENEA vs MGTX Comparison
Compare SENEA & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SENEA
- MGTX
- Stock Information
- Founded
- SENEA 1949
- MGTX 2015
- Country
- SENEA United States
- MGTX United States
- Employees
- SENEA N/A
- MGTX N/A
- Industry
- SENEA Packaged Foods
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SENEA Consumer Staples
- MGTX Health Care
- Exchange
- SENEA Nasdaq
- MGTX Nasdaq
- Market Cap
- SENEA 699.2M
- MGTX 670.2M
- IPO Year
- SENEA N/A
- MGTX N/A
- Fundamental
- Price
- SENEA $104.32
- MGTX $8.17
- Analyst Decision
- SENEA
- MGTX Strong Buy
- Analyst Count
- SENEA 0
- MGTX 2
- Target Price
- SENEA N/A
- MGTX $24.00
- AVG Volume (30 Days)
- SENEA 43.5K
- MGTX 573.6K
- Earning Date
- SENEA 08-07-2025
- MGTX 08-14-2025
- Dividend Yield
- SENEA N/A
- MGTX N/A
- EPS Growth
- SENEA N/A
- MGTX N/A
- EPS
- SENEA 6.24
- MGTX N/A
- Revenue
- SENEA $1,571,618,000.00
- MGTX $37,917,000.00
- Revenue This Year
- SENEA N/A
- MGTX $228.65
- Revenue Next Year
- SENEA N/A
- MGTX $145.06
- P/E Ratio
- SENEA $16.73
- MGTX N/A
- Revenue Growth
- SENEA 7.30
- MGTX 366.84
- 52 Week Low
- SENEA $59.21
- MGTX $3.85
- 52 Week High
- SENEA $107.36
- MGTX $8.98
- Technical
- Relative Strength Index (RSI)
- SENEA 56.28
- MGTX 55.70
- Support Level
- SENEA $102.57
- MGTX $7.53
- Resistance Level
- SENEA $105.85
- MGTX $8.63
- Average True Range (ATR)
- SENEA 2.60
- MGTX 0.47
- MACD
- SENEA -0.10
- MGTX -0.02
- Stochastic Oscillator
- SENEA 56.26
- MGTX 66.17
About SENEA Seneca Foods Corp.
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.